أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - atomoxetinum hýdróklóríð - hart hylki - 100 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - atomoxetinum hýdróklóríð - hart hylki - 25 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - atomoxetinum hýdróklóríð - hart hylki - 40 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - atomoxetinum hýdróklóríð - hart hylki - 60 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - atomoxetinum hýdróklóríð - hart hylki - 80 mg

الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanid - berklar, fjölþol-þolir - antimycobacterials - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 og 5. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - blöðruhálskirtli - innkirtla meðferð - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - bicalutamidum inn - filmuhúðuð tafla - 150 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - bicalutamidum inn - filmuhúðuð tafla - 50 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

astrazeneca ab - goserelinum acetat - vefjalyf - 10,8 mg